Özet:

Our purpose in the study is to identify toxoplasma, rubella, sitomegalovirus, HBV, antiHbs, HCV, HIV seroprevelans in the first trimester of pregnancy and to investigate the relationship between parity conditions and age groups. Between November 2011 and February 2013, the Bayrampaşa State Hospital, which applied to the female diseases and birth clinic, was evaluated in our study of 2,900 12 weeks and six pregnancies, ranging from age 16 to 45. Results of toxoplasma, Rubella, Sitomegalovirus, HBV, AntiHbs, HCV, HIV studied in appropriate pregnancies were analyzed. The age groups, Gravide, Parite numbers were questioned. The average age of the pregnancies involved in the study was 27.78±5.57 (16-45), the average pregnancy was 2.21±1.39 (1-8), the average parity was 0.78±0.89 (0-5), and the average pregnancy week in the application was 8±3 (5-12) Toxoplasma Ig G, Rubella Ig G, Sitomegalovirus Ig G, HbsAg, antiHbs, antiHCV, anti-HIV seropositivity respectively; 31.2%, 95.7%, 99.2%, 2.4%, 22.1%, 0.1%, while 0.7; Toxoplasma Ig M, Rubella Ig M, Sitomegalovirus Ig M seropositivity respectively; 0.9%, 0.15%, 0.7%. The toxoplasma seropositivity rate is similar to the Turkish data. Rubella seronegativity has been found low compared to the data in Turkey and with pre-gravity vaccination this value can be pulled to the level of European countries. CMV seropositivity is quite high in our study and indicates a low socioeconomic level. HBsAg, anti-HBs, anti-HCV, anti-HIV levels have been determined close to the average in Turkey. According to them, in addition to the routine TORCH screening, HBsAg and anti-HBs screening appear suitable, while anti-HCV and anti-HIV screening is not cost-effective.